Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 24.62
-0.87 (-3.41%)
Aug 26, 2026, 3:04 PM CST
SHE:002317 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 21,665 | 16,132 | 10,279 | 13,607 | 21,822 | 9,641 | |
Market Cap Growth | 14.29% | 56.94% | -24.46% | -37.64% | 126.34% | 8.90% |
Enterprise Value | 20,685 | 15,382 | 8,899 | 12,528 | 21,472 | 9,286 |
Last Close Price | 25.49 | 18.81 | 11.85 | 15.44 | 25.65 | 11.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 107.08 | 58.50 | - | 51.69 | 67.76 | 34.73 |
Forward PE | 79.66 | 36.95 | 33.75 | 16.57 | 16.57 | 16.57 |
PS Ratio | 9.74 | 6.40 | 4.17 | 5.21 | 8.15 | 3.97 |
PB Ratio | 5.30 | 3.89 | 2.56 | 3.01 | 5.72 | 2.73 |
P/TBV Ratio | 6.15 | 4.55 | 2.87 | 3.68 | 6.75 | 3.21 |
P/FCF Ratio | 45.04 | - | 93.80 | - | - | 23.57 |
P/OCF Ratio | 26.84 | 52.86 | 30.43 | 71.39 | 345.99 | 15.48 |
PEG Ratio | - | 2.09 | 2.09 | 1.43 | 1.43 | 1.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 9.30 | 6.10 | 3.61 | 4.80 | 8.02 | 3.82 |
EV/EBITDA Ratio | 62.65 | 38.31 | 27.02 | 26.94 | 44.93 | 20.08 |
EV/EBIT Ratio | 103.16 | 53.83 | 43.00 | 36.19 | 56.44 | 25.22 |
EV/FCF Ratio | 43.00 | - | 81.21 | - | - | 22.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.03 | 0.08 | 0.08 | 0.16 | 0.24 | 0.15 |
Debt / EBITDA Ratio | 0.37 | 0.81 | 0.92 | 1.55 | 1.88 | 1.11 |
Debt / FCF Ratio | 0.26 | - | 2.79 | - | - | 1.26 |
Net Debt / Equity Ratio | -0.26 | -0.24 | -0.39 | -0.35 | -0.14 | -0.22 |
Net Debt / EBITDA Ratio | -3.27 | -2.45 | -4.75 | -3.44 | -1.08 | -1.68 |
Net Debt / FCF Ratio | -2.22 | 89.74 | -14.27 | 9.28 | 2.53 | -1.90 |
Asset Turnover | 0.44 | 0.47 | 0.41 | 0.43 | 0.50 | 0.50 |
Inventory Turnover | 2.68 | 2.76 | 2.36 | 2.16 | 2.02 | 1.90 |
Quick Ratio | 3.49 | 3.59 | 2.43 | 3.30 | 2.39 | 4.01 |
Current Ratio | 4.86 | 4.24 | 2.88 | 3.90 | 2.92 | 5.10 |
Return on Equity (ROE) | 4.64% | 6.54% | -8.76% | 5.99% | 8.58% | 7.67% |
Return on Assets (ROA) | 2.48% | 3.34% | 2.15% | 3.54% | 4.45% | 4.75% |
Return on Invested Capital (ROIC) | 6.10% | 9.16% | 7.70% | 9.80% | 10.76% | 11.95% |
Return on Capital Employed (ROCE) | 4.60% | 6.50% | 4.80% | 6.40% | 8.20% | 8.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.92% | 1.71% | -2.91% | 1.93% | 1.48% | 2.88% |
FCF Yield | 2.22% | -0.07% | 1.07% | -1.27% | -0.94% | 4.24% |
Dividend Yield | 0.70% | 1.06% | 1.69% | 1.29% | 0.78% | 1.76% |
Payout Ratio | 85.37% | 61.76% | - | 65.15% | 56.33% | 67.30% |
Buyback Yield / Dilution | -1.97% | -0.56% | -1.00% | -2.19% | -1.50% | 1.45% |
Total Shareholder Return | -1.27% | 0.51% | 0.68% | -0.89% | -0.72% | 3.21% |